Lepu Medical Technology (Beijing) Co., Ltd. Stock

Equities

300003

CNE100000H44

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-29 pm EDT 5-day change 1st Jan Change
14.75 CNY +0.55% Intraday chart for Lepu Medical Technology (Beijing) Co., Ltd. +6.12% -8.73%
Sales 2024 * 8.89B 1.23B Sales 2025 * 10.13B 1.4B Capitalization 27.4B 3.78B
Net income 2024 * 1.98B 274M Net income 2025 * 2.28B 315M EV / Sales 2024 * 2.66 x
Net cash position 2024 * 3.75B 519M Net cash position 2025 * 4.57B 631M EV / Sales 2025 * 2.25 x
P/E ratio 2024 *
13.9 x
P/E ratio 2025 *
12.1 x
Employees -
Yield 2024 *
2.39%
Yield 2025 *
2.5%
Free-Float 93.79%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.55%
1 week+6.12%
Current month+7.04%
1 month+7.04%
3 months+6.73%
6 months-13.94%
Current year-8.73%
More quotes
1 week
13.67
Extreme 13.67
14.86
1 month
12.91
Extreme 12.91
14.86
Current year
11.60
Extreme 11.6
16.27
1 year
11.60
Extreme 11.6
25.26
3 years
11.60
Extreme 11.6
35.62
5 years
11.60
Extreme 11.6
46.96
10 years
8.95
Extreme 8.95
46.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 21-04-25
Director of Finance/CFO 51 07-02-28
Chairman 61 -
Members of the board TitleAgeSince
Chairman 61 -
Director/Board Member 57 13-12-31
Director/Board Member 57 20-01-21
More insiders
Date Price Change Volume
24-04-30 14.75 +0.55% 16,013,910
24-04-29 14.67 +2.16% 23,253,520
24-04-26 14.36 +1.13% 20,018,870
24-04-25 14.2 +2.82% 24,352,480
24-04-24 13.81 -1.36% 19,701,810

End-of-day quote Shenzhen S.E., April 29, 2024

More quotes
Lepu Medical Technology (Beijing) Co., Ltd. specialized in the design, manufacture and marketing of medical devices and equipment. The group is also involved in the development and manufacturing of active pharmaceutical ingredients. Net sales break down by activity as follows: - sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery; - sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.; - sale of digital health and hospital network management solutions (11.6%). China accounts for 64.7% of net sales.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
14.75 CNY
Average target price
20.69 CNY
Spread / Average Target
+40.27%
Consensus
  1. Stock Market
  2. Equities
  3. 300003 Stock